1756-8935-6-S1-O33 1756-8935 Oral presentation <p><it>XACT</it>, a long non-coding transcript coating the active X chromosome in human pluripotent cells</p> VallotCéline HuretChristophe LesecqueYann ReschAlissa OudrhiriNoufϊssa BennaceurAnnelise DuretLaurent RougeulleClaire

Univ Paris Diderot, Sorbonne Paris Cité, Epigenetics and Cell Fate, Paris, France

CNRS, UMR7216 Epigenetics and Cell Fate, Paris, France

Laboratoire de Biométrie et Biologie Evolutive, UMR CNRS 5558, Université de Lyon, Université Lyon 1, Villeurbanne, France

Stem Cell Institute, UCHC, Farmington, CT, USA

INSERM U935, Université Paris Sud 11, AP-HP, Villejuif 94802, France

Epigenetics & Chromatin <p>Epigenetics and Chromatin: Interactions and processes</p>Publication of this supplement was funded by BioMed Central.Meeting abstracts<p>Epigenetics and Chromatin: Interactions and processes</p>Boston, MA, USA11-13 March 2013http://conf.epigeneticsandchromatin.com/1756-8935 2013 6 Suppl 1 O33 http://www.epigeneticsandchromatin.com/content/6/S1/O33 10.1186/1756-8935-6-S1-O33
1832013 2013Vallot et al; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

X-chromosome inactivation (XCI), the dosage compensation process that equalizes X-linked gene expression between sexes, has mostly been studied in the mouse, where the central role for the non-coding RNA Xist in the initiation and spreading of the process was demonstrated. Although Xist is conserved in humans 1 , very little is known concerning its regulation and function in this species. Several lines of evidence moreover suggest that different strategies have been adopted in the human to control XCI as compared to the mouse. In particular, in human pre-implantation development, XIST RNA coats the X chromosome(s) in both male and female embryos without inducing X-chromosome silencing 2 . This indicates that XIST expression and X-inactivation can be uncoupled during human embryogenesis and that other elements likely participate to the control of X chromosome activity in humans.

XCI is established early during embryonic development, and embryonic stem cells can be used to decipher the kinetics and the molecular actors of the process. Human female embryonic stem cells (hESC) can be found in different configurations regarding XIST expression: most female hESC have already undergone XCI but tend to spontaneously lose XIST expression 3 . In the course of an RNA-seq analysis of female hESC, we identified an extended and un-annotated transcribed region producing a long unspliced, likely non-coding nuclear RNA. RNA-FISH analysis reveals that this transcript is expressed from, and coats the active X chromosome. We called this transcript XACT, for X-active coating transcript. In female hESC in which XIST is repressed, XACT is expressed from and coats both Xs, and this correlates with significant reactivation of the inactive X chromosome. Expression of XACT appears to be specific for pluripotent cells as its expression decreases during differentiation. Finally, we provide evidence that XACT is not conserved in the mouse.

In conclusion, we have identified XACT as the first long ncRNA that coats the active X chromosome in human. Given its expression profile and lack of conservation, it is tempting to speculate that XACT is involved in the peculiar control of XCI initiation in human.

<p>Localization of the X inactivation centre on the human X chromosome in Xq13</p>BrownCJLafreniereRGPowersVESebastioGBallabioAPettigrewALLedbetterDHLevyECraigIWWillardHFNature1991348284<p>Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development</p>OkamotoIPatratCThepotDPeynotNFauguePDanielNDiabangouayaPWolfJPRenardJPDuranthonVHeardENature201147237037410.1038/nature0987221471966<p>Linking X chromosome inactivation to pluripotency: Necessity or Fate?</p>MakhloufMRougeulleCTrend Mol Med201117326336